Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-623-8 | CAS number: 108-86-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
acute toxicity, oral (no guideline followed, RL2), male rats: LD50 = 2383 mg/kg bw (fasted)
acute toxicity, inhalation (ODCD 403, RL2), male/female rats: LC50 = 29.7 mg/L (calculated); LT50 = 1.8 h
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 Nov 1980 - 4 Feb 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- (no GLP, not according to guideline)
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test: Single oral dose administration of three doses of bromobenzene administered to fasted and non-fasted rats
- Short description of test conditions: 10 males per dose were treated and observed for 14 - 16 days
- Parameters analysed / observed: mean time of death, clinical signs, mean body weight change from day 1 to 14, LD50 - GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source of test material: Fischer Chemicals, Fairlawn, NJ, USA - Species:
- rat
- Strain:
- other: Crl-CD
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratory, North Wilmington, MA, USA
- Age at study initiation: Approx. 60 days
- Weight at study initiation: 220 - 280 g
- Fasting period before study: Yes, groups of fasted (24 h) and non-fasted animals were dosed
- Diet: Purina Rat Chow (Ralston Purina Co., St Louis, USA), ad libitum
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 10 - 25%
MAXIMUM DOSE VOLUME APPLIED: 4.5 mL
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Dose levels were selected based on a range-finding study to deine a dose producing mortality. - Doses:
- fasted animals: 2000, 2800 and 3500 mg/kg
non-fasted: 3000, 3500 and 4000 mg/kg - No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 - 16 days
- Frequency of weighing: Individual body weights were determined on Days 0, 1 and 14
- Necropsy of survivors performed: no
- Other examinations performed: mortality, clinical signs, body weight - Statistics:
- LD50 values were determined by Probit analysis (Finney, 1971).
- Preliminary study:
- One rat was treated with 670 - 7500 mg/kg bw to roughly define the dose producing mortality. Mortality was observed starting at 3400 mg/kg bw.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3 591 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: non-fasted rats
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 383 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: fasted rats
- Mortality:
- Fasted animals
2000 mg/kg: 3/10 animals died
2800 mg/kg: 6/10 animals died
3500 mg/kg: 10/10 animals died
Non-fasted animals
3000 mg/kg: 1/10 animals died
3500 mg/kg: 4/10 animals died
4000 mg/kg: 8/10 animals died - Clinical signs:
- other: Fasted animals All doses: stained and wet perineal area, stained face, lacrimation, chromodacryorrhea, diarrhea and congestion 2000 mg/kg: weakness 2800 mg/kg: weakness, lethargy, prostration 3500 mg/kg: salvation, tremors, prostration Non-fasted animals
- Gross pathology:
- Not performed
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation(EC) No. 1272/2008
- Conclusions:
- CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
Reference
Table 1: Results of acute oral toxicity study
Dose [mg/kg] |
Mortality |
Day of deatha |
Weight decrease day 0-1 [g]a |
Weight increase day 0-14 [g]a |
Fasted |
|
|
|
|
2000 |
3 |
2 ± 1 |
7 ± 2 |
36 ± 4 |
2800 |
6 |
2 ± 1 |
8 ± 1 |
40 ± 2 |
3500 |
10 |
2 ± 1 |
5 ± 2 |
- |
Non-fasted |
|
|
|
|
3000 |
1 |
3 ± 0 |
11 ± 3 |
17 ± 4 |
3500 |
4 |
2 ± 1 |
9 ± 4 |
16 ± 4 |
4000 |
8 |
3 ± 2 |
12 ± 2 |
20 ± 3 |
a: mean ± SD
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 383 mg/kg bw
- Quality of whole database:
- The available information comprises an adequate and reliable study, and is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- Please refer to analogue justification provided in IUCLID section 13
- Principles of method if other than guideline:
- The acute toxic potential following inhalation was determined according to the Inhalation Hazard Test. Animals were exposed to a fixed concentration (66 mg/L) and the time after which no or 50% of test animals dies was determined.
- GLP compliance:
- no
- Test type:
- other: Inhalation Hazard Test
- Limit test:
- no
- Species:
- other: not specified
- Strain:
- not specified
- Sex:
- male/female
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: whole-body exposure system (only general information given)
- Exposure chamber volume: 1 - 2L
- System of generating particulates/aerosols: Glass flask generator. The part of the generator containing the glass fritt and filled with the test substance dips into a thermostated liquid bath kept at the 20 °C
- Temperature in air chamber: saturation temperature (e.g. 20 °C)
- Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- gravimetrically from the weight loss of the material and the volume of air passing through the generator
- Concentrations:
- 66 mg/L (saturated vapour pressure at 20 °C)
- No. of animals per sex per dose:
- 3
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Sex:
- male/female
- Dose descriptor:
- other: LT50
- Effect level:
- 66 mg/L air (nominal)
- Based on:
- test mat.
- Exp. duration:
- 1.8 h
- Remarks on result:
- other: Exposure for 1.8 h to 66 mg/L test substance resulted in mortality of 50% of test animals within the 14 day observation period.
- Sex:
- male/female
- Dose descriptor:
- other: LT0
- Effect level:
- 66 mg/L air (nominal)
- Based on:
- test mat.
- Exp. duration:
- 0.17 h
- Remarks on result:
- other: Exposure for 0.17 h to 66 mg/L test substance did not result in any mortality within the 14 day observation period.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 29.7 mg/L air (nominal)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: Calculation according to Haber`s law (C∙t = k)
- Mortality:
- 66 mg/L: 3/6 animals died after exposure for 1.8 h
- Clinical signs:
- other: not examined
- Body weight:
- not examined
- Gross pathology:
- not examined
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- CLP: Acute Tox. 4, H332
Although available data on acute toxicity following inhalation do not meet the classification criteria according to Regulation (EC) 1272/2008, the registrant follows the harmonised classification.
Reference
The Inhalation Hazard Test was performed to determine the hazard of volatile substances including chlorobenzene. 3 male and 3 female animals were exposed to 66 mg/L (nominal concentration) in a glass system with tubes.
For the generation of a vapor saturated inhalation atmosphere, a glass flask generator was used. The LT0 (time T after which no animals died within 14 days of post-exposure observation period) and the LT50 (time of exposure after which 50% of the animals died within 14 days of the post-exposure observation period) were calculated.
In this inhalation hazard test, the value of LT0 was 0.17 h and the value of LT 50 was 1.8 h.
The LC50 was calculated according to the Haber´s law: LC50= 66 mg/L (1.8 h /4 h) = 29.7 mg/L.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 29 700 mg/m³ air
- Quality of whole database:
- The available information comprises an adequate and reliable study (Klimisch score 2 due to read-across) from a reference substance with similar structure. Read-across is justified based on common functional groups and structural similarities (please refer to analogue justification). The selected study is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.5, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute toxicity
Justification for read-across
There are data available regarding acute oral toxicity for bromobenzene (CAS 108-86-1). In addition, read-across from an appropriate substance (chlorobenzene (CAS 108-90-7)) is taking into account for the evaluation of inhalation toxicity in accordance with Regulation (EC) No 1907/2006, Annex XI, 1.5. Structural similarities and comparable toxicokinetic properties of the source and target substance are the basis of read-across. A detailed justification for the analogue read-across approach is provided in the technical dossier (see IUCLID Section 13).
Acute oral toxicity
An acute oral toxicity study performed with brombenzene is available (Dashiell et al., 1984). In this study, groups of 10 Crl-CD male rats were administered single doses of the test substance via oral gavage. Based on the outcome of a dose-range finding study to roughly estimate lethal doses, fasted males received doses of 2000, 2800 and 3500 mg bromobenzene/kg bw. In addition, ten non-fasted males received doses of 3000, 3500 and 4000 mg/kg bw. The animals were observed for 14 - 16 days after substance administration. Mortality, clinical signs and effects on body weights were noted in all groups. In fasted animals, 3/10, 6/10 and 10/10 animals died within 4 days after substance application at 2000, 2800 and 3500 mg/kg bw, respectively. In non-fasted animals, 1/10, 4/10 and 8/10 animals died within 4 days after test substance administration at 3000 , 3500 and 4000 mg/kg bw, respectively. The acute oral LD50 value was considered to be 2383 mg/kg for fasted and 3591 mg/kg for non-fasted animals (LD50 value of non-fasted animals is not taking into account for hazard evaluation). In conclusion, the derived LD50 value for fasted animals exceeds the currently applied limit dose of 2000 mg/kg bw. Thus, based on the conducted study, bromobenzene does not meet the classification criteria defined for acute oral toxicity according to Regulation (EC) No 1272/2008.
Acute dermal toxicity
No data on acute dermal toxicity are available for bromobenzene, which is in line with the standard information requirements defined in Annex VII of Regulation (EC) No 2006/1907.
Acute inhalation toxicity
The Inhalation Hazard Test was performed to determine the hazard of volatile substances including chlorobenzene. 3 male and 3 female animals were exposed to 66 mg/L (nominal concentration) in a glass system with tubes (Klimisch, 1988). For the generation of a vapor saturated inhalation atmosphere, a glass flask generator was used. The LT0 (time T after which no animals died within 14 days of post-exposure observation period) and the LT50 (time of exposure after which 50% of the animals died within 14 days of the post-exposure observation period) were calculated.
Based on the results of the conducted study, a LT0 of 0.17 h and a LT50 of 1.8 h was derived. Considering Haber’s Law (C.t = k) according to Regulation (EC) 1272/2008 and Guidance on information requirements and chemical safety assessment Chapter R.7a: Endpoint specific guidance (ECHA, 2008), a time-extrapolated LC50 value of 29.7 mg/L is achieved (66 [mg/L] x 1.8 h = c [mg/L] x 4h). In conclusion, based on the available data, the extrapolated LC50 value exceeds the defined cut off value of 20 mg/L. However, according to the harmonised classification, chlorobenzene is considered to meet the classification criteria for Acute toxicity, Cat. 4, H332 according to Regulation (EC) No 1272/2008.
Justification for classification or non-classification
Based on the available data on acute oral toxicity, bromobenzene does not meet the classification criteria according to Regulation (EC) 1272/2008. No data on the dermal route are available.
The analogue substance chlorobenzene (CAS 108-90-7) is classified as Acute Tox. 4, H332 according to Annex VI of Regulation (EC) No 1272/2008. Although the available data on acute toxicity following inhalation do not meet the classification criteria according to Regulation (EC) No 1272/2008, the registrant follows the harmonised classification of the source substance chlorobenzene and applies the classification for the target susbtance bromobenzene based on read across and self classification. Thus, based on the analogue approach, bromobenzene is considered to meet the classification criteria according to Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.